Sophia Genetics, Paragon Genomics Team on SARS-CoV-2 Testing
The collaboration will provide a COVID-19 test offering that combines Paragon Genomics' CleanPlex SARS-CoV-2 NGS panel reagent kit for whole-genome sequencing of the coronavirus with the advanced analytical power of the SOPHiA platform.
Crumpled Graphene Improves Detection of DNA Cancer Markers
Using computer simulations, researchers found that cavities within the altered graphene served as electrical hotspots, acting as a trap for DNA and RNA molecules, extending the time they engage with the rough graphene surface.
Ex-Geisinger Principals Team with Genome Medical to Expand Genetic Services
Hunt Willard signs on as chief science officer and VP of medical affairs, and Erica Ramos as VP of population genomics.
Novacyt COVID-19 Diagnostic Gains FDA Emergency Use Authorization
Under the EUA designation, the Primerdesign test is authorized only for the detection of RNA from SARS-CoV-2 virus and diagnosis of SARS-CoV-2 virus infection, and not for any other viruses or pathogens.
Cancer Gets a Global Genomic Map
The Pan-Cancer Analysis of Whole Genomes incorporated 2,658 whole genomes, 38 tumor types, 1,188 transcriptomes, and 1,300 scientists from 37 countries.
U.K. to Use Nanopore Sequencing to Map COVID-19 Spread
A notable addition to the effort is a team from the University of Birmingham, led by Nick Loman, Ph.D., professor of Microbial Genomics and Bioinformatics in the Institute of Microbiology and Infection, whose lab is known for fusing cutting-edge sequencing with microbial genomics.
New Study Suggests COVID-19 Reinfection Unlikely
The study used four adult Chinese rhesus macaques and found that those monkeys that had been re-exposed to SARS-CoV-2, like the unexposed control monkey, showed no recurrence of COVID-19.
Biodesix, Bio-Rad Pursue FDA EUA Approval for ddPCR-Based COVID-19 Test
Emergency Use Authorization (EUA) would enable Biodesix and Bio-Rad to begin testing in the U.S. using the Droplet Digital PCR system.
Clinical Research in a Real-Time Sequencing Age
Sponsor: Oxford NanoporeOxford Nanopore’s DNA/RNA sequencing technology delivers ultra-long reads (up to 2 Mb), enabling rapid and comprehensive analysis of variants. With devices scalable from portable to benchtop, nanopore sequencing offers a cost-effective solution to the challenges faced by traditional sequencing platforms.
Genomind to Ship Mental Health PGx Test Directly to Patients
Under the direct-to-patient shipping offering, physicians can order the test and Genomind will expedite shipping of the test kit to the address provided by the patient. Patients will follow instructions to provide a sample via a simple cheek swab and return it to Genomind’s lab for processing.
